Screener
Gyre Therapeutics, Inc. GYRE Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s return on invested capital?
- Gyre Therapeutics, Inc. (GYRE) reported return on invested capital of -26.7% in Q2 2026.
- How has Gyre Therapeutics, Inc.'s return on invested capital changed year-over-year?
- Gyre Therapeutics, Inc.'s return on invested capital decreased by 540.1% year-over-year, from 6.1% to -26.7%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Gyre Therapeutics, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude